Opening book details…
About this Medicine article
370 A phase Ib study of escalating doses of Vascular Endothelial Growth Factor (VEGF) tyrosine kinase inhibitor Tivozanib and FOLFOX6 in patients with advanced gastrointestinal (GI) tumors by F. Eskens; C. Oldenhuis; P. Bhargava; W. Loos; B. Esteves; L. van Doorn; M. Cotreau; R. Dillon; J. Gietema; E. de Vries is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- F. Eskens; C. Oldenhuis; P. Bhargava; W. Loos; B. Esteves; L. van Doorn; M. Cotreau; R. Dillon; J. Gietema; E. de Vries
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2010
- Language
- EN
- Field
- Medicine (Health Sciences)